Balance Sheet HealthZero reported debt and very low historical leverage provide durable financial flexibility. Low leverage reduces refinancing risk, supports investment in tooling and product development, and preserves capacity to absorb hospital procurement cyclicality without threatening solvency.

Margin SustainabilityHigh gross margins reflect differentiated, precision surgical instruments and pricing power versus commodity vendors. Sustained gross margins allow funding of R&D and manufacturing quality, supporting long-term product competitiveness and protecting operating profitability against moderate sales shocks.

Niche Surgical FranchiseFocused product portfolio and long-term hospital contracts create repeatable demand and higher switching costs. This niche positioning and distribution partnerships support steady institutional sales, enabling predictable servicing cycles and gradual international expansion over time.

Bears Say

Revenue MomentumMaterial slowdown in top-line growth reduces the firm's ability to leverage fixed manufacturing costs and compress unit economics gains. If persistent, slower revenue restricts reinvestment capacity, lengthens payback on new product launches, and may signal market saturation or competitive share erosion.

Cash Conversion VolatilitySharp FCF decline and weak cash-to-earnings conversion indicate volatile working capital or timing of investments. That volatility undermines the practical benefits of a debt-free balance sheet by limiting internally generated funds for capex, acquisitions, or shareholder returns over multi-quarter horizons.

Operating Margin PressureCompression of operating margin versus the prior year signals rising cost or price pressure in the business. Sustained margin erosion would reduce return on equity and cash flow available for growth initiatives, possibly requiring restructuring or pricing actions that could strain customer relationships.

STIL FAQ

What was Stille AB’s price range in the past 12 months?

Stille AB lowest stock price was kr143.00 and its highest was kr254.00 in the past 12 months.

What is Stille AB’s market cap?

Stille AB’s market cap is kr1.67B.

When is Stille AB’s upcoming earnings report date?

Stille AB’s upcoming earnings report date is Apr 23, 2026 which is in 50 days.

How were Stille AB’s earnings last quarter?

Stille AB released its earnings results on Feb 12, 2026. The company reported kr3.37 earnings per share for the quarter, beating the consensus estimate of kr1.818 by kr1.552.

Is Stille AB overvalued?

According to Wall Street analysts Stille AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Stille AB pay dividends?

Stille AB pays a Annually dividend of kr1.8 which represents an annual dividend yield of N/A. See more information on Stille AB dividends here

What is Stille AB’s EPS estimate?

Stille AB’s EPS estimate is 1.9.

How many shares outstanding does Stille AB have?

Stille AB has 8,985,447 shares outstanding.

What happened to Stille AB’s price movement after its last earnings report?

Stille AB reported an EPS of kr3.37 in its last earnings report, beating expectations of kr1.818. Following the earnings report the stock price went up 21.212%.

Which hedge fund is a major shareholder of Stille AB?

Currently, no hedge funds are holding shares in SE:STIL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Stille AB

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; needle holders, and wire twisting and holding forceps; and osteotomes, chisels, retractors and skin hooks, scissors, and other products, as well as c-arm tables. The company also provides ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries. In addition, it provides instrument repair, maintenance, and inspection services. Further, the company's products are used in various open surgeries. It has a collaboration agreement with GE Healthcare and distribution agreement with Synovis Micro. The company sells through OEM manufacturers of C-frames, distributors, and direct sales. The company was founded in 1841 and is headquartered in Torshälla, Sweden. Stille AB is a subsidiary of Linc AB.